Blue Horseshoe Stocks: Epic BPTH Run

Bio-Path Holdings, Inc. BPTH

We’ve been talking about BPTH all week, after the stock we tagged as a bottom watch play in our morning report on January 23rd had come up from our observed low of 2.65 to nearly the $15-mark. It was an incredible gain indeed, but nothing could have prepared us for what was to come.

Yesterday, following the company’s clinical update on its Phase 2 acute myeloid leukemia drug, prexigebersen, we saw an explosion on the chart that can only be described as the rarest of the rare. BPTH shot up from a daily low of 17.01 to an astounding high of 73.52! That worked out to an intraday swing of 332% As measured from the low following our January alert on the stock, BPTH posted an increase of  2,674% in a matter of just five weeks.

The stock pulled back to the high $30′s following that epic run, so it would appear that the above-mentioned figure will be the final maximum gain on our idea. While this has a chance to go down as our best stock call of the year, the chances that we score bigger gains on options ideas are extremely high. So we encourage any non-subscribers reading this to sign up as soon as possible!


Fresh Options Ideas

Speaking of options, which have also brought us several multi-bag gain opportunities this week, we’ll go ahead and close out this incredibly successful week with a pair of ideas that seem to be good bets here in the premarket. Horrid payroll numbers are contributing to what appears to be an impending bearish day for the markets.

SPY Weekly $274.50-273 Puts*
BIG 03/15 $35-37.50 Calls

*Never trade weekly options on a Friday unless you are an expert level trader with access to disposable funds.


Extended Watchlist:
DSKE, TRIL, SAEX, SEEL, PULM, TROV, TVIX, XXII

Blue Horseshoe Stocks: Options 5-Pack

GlaxoSmithKline plc GSK – Final Recap

Wednesday morning, we formulated an idea for the GSK options chain, which we updated our reader on just yesterday. But after a second consecutive solid session, we did observe some new highs in all three of our designated contracts, which were the GSK Weekly $39.50-40.50 Calls.

The updated two-day swing ranges on each of those ideas:

$39.50 Calls – Range: .65-1.40 – Max Gain: 115%
$40 Calls – Range: .15-1.00 – Max Gain: 566%
$40.50 Calls – Range: .10-.60 – Max Gain: 500%

GSK just continues the trend of fantastic options calls we’ve made in 2019 so far. While we don’t have exact figures worked out, it would seem at least 80-90% of the options ideas we’ve formulated have produced multi-bag gain opportunities, and we invite our readers to go through our newsletter feed at BlueHorseshoeStocks.com and see for yourself!
_____

Fresh Idea:
In the spirit of the great success we’ve had with options, we’re going to finish out the week in a big way with five fresh ideas!

Expedia Group, Inc. EXPE Weekly $134-136 Calls
Coty, Inv. COTY Weekly $8-9 Calls
SPDR S&P 500 ETF (SPY) Weekly $270.50-269 Puts
Sketchers USA Inc. SKX Weekly $30-33 Calls
Tupperware, Inc. TUP 07/19 $25 & $30 Calls

*Please note that our ideas for trading contracts with a weekly expiration on Fridays are intended STRICTLY for advanced level traders with disposable funds with which to work!


3pea International, Inc. TPNL

We also want to briefly recap the solid singkle-session performance of TPNL following its inclusion in yesterday’s morning’s premarket report. The stock produced an intraday run from 5.06 to 7.18, which works out to a gain of 42% and was good for the top gainer spot on the entire NASDAQ yesterday.


Extended Watchlist:
CNHC, DRVD, CPRX, DPW, MHK, PLX, BECN, CLD, DSKE